{"id":399205,"date":"2025-05-28T01:05:00","date_gmt":"2025-05-27T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/les-benefices-et-les-risques-que-disent-les-donnees-actuelles\/"},"modified":"2025-05-28T02:46:12","modified_gmt":"2025-05-28T00:46:12","slug":"les-benefices-et-les-risques-que-disent-les-donnees-actuelles","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/les-benefices-et-les-risques-que-disent-les-donnees-actuelles\/","title":{"rendered":"les b\u00e9n\u00e9fices et les risques : Que disent les donn\u00e9es actuelles ?"},"content":{"rendered":"\n

Bien qu’il n’y ait pas eu r\u00e9cemment de nouvelle autorisation de mise sur le march\u00e9 pour les inhibiteurs JAK oraux (JAK-i) dans la dermatite atopique (DA), des r\u00e9sultats d’\u00e9tudes int\u00e9ressants ont \u00e9t\u00e9 publi\u00e9s. Celles-ci mettent en lumi\u00e8re la s\u00e9curit\u00e9 du baricitinib, de l’abrocitinib et de l’upadacitinib en r\u00e9f\u00e9rence \u00e0 l’avis de l’EMA sur les JAK-i publi\u00e9 il y a quelque temps. Dans l’UE, le baricitinib a re\u00e7u une extension d’indication pour les patients atteints de la MA \u00e2g\u00e9s de plus de 2 ans. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Bien qu’il n’y ait pas eu r\u00e9cemment de nouvelle autorisation de mise sur le march\u00e9 pour les inhibiteurs JAK oraux (JAK-i) dans la dermatite atopique (DA), des r\u00e9sultats d’\u00e9tudes int\u00e9ressants……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":399208,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"JAK-i oraux dans la dermatite atopique ","footnotes":""},"category":[11349,11362,11527,11535,11549],"tags":[67783,82431,82434,65588,12636,15569,17477,65783,68790,18789,17479,15564,65585,16817,69921,20444,16820,82433],"powerkit_post_featured":[],"class_list":["post-399205","post","type-post","status-publish","format-standard","has-post-thumbnail","category-allergologie-et-immunologie-clinique","category-dermatologie-et-venerologie","category-etudes","category-rapports-de-congres","category-rx-fr","tag-abrocitinib-fr","tag-barictinib-fr","tag-breeze-ad-peds-fr","tag-cibinqo-fr","tag-dermatite-atopique-fr","tag-inhibiteur-de-jak","tag-inhibiteurs-jak","tag-jak-i-fr","tag-januskinases","tag-meta-analyse-fr","tag-olumiant-fr","tag-petites-molecules","tag-rinvoq-fr","tag-risques","tag-surveillance-orale","tag-upadacitinib-fr","tag-utilisent","tag-yoon-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-12 00:33:06","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":399207,"slug":"benefici-e-rischi-cosa-dicono-i-dati-attuali","post_title":"Benefici e rischi: Cosa dicono i dati attuali?","href":"https:\/\/medizinonline.com\/it\/benefici-e-rischi-cosa-dicono-i-dati-attuali\/"},"pt_PT":{"locale":"pt_PT","id":399210,"slug":"beneficios-e-riscos-o-que-dizem-os-dados-actuais","post_title":"Benef\u00edcios e riscos: O que dizem os dados actuais?","href":"https:\/\/medizinonline.com\/pt-pt\/beneficios-e-riscos-o-que-dizem-os-dados-actuais\/"},"es_ES":{"locale":"es_ES","id":399231,"slug":"beneficios-y-riesgos-que-dicen-los-datos-actuales","post_title":"Beneficios y riesgos: \u00bfQu\u00e9 dicen los datos actuales?","href":"https:\/\/medizinonline.com\/es\/beneficios-y-riesgos-que-dicen-los-datos-actuales\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/399205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=399205"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/399205\/revisions"}],"predecessor-version":[{"id":399211,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/399205\/revisions\/399211"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/399208"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=399205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=399205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=399205"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=399205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}